Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Abraham Lebenthal, pleural mesothelioma doctor

Dr. Abraham Lebenthal

Thoracic Surgeon

Thoracic surgeon Dr. Abraham Lebenthal specializes in the treatment of pleural mesothelioma, splitting his time between Dana-Farber Cancer Institute and the nearby VA Boston Healthcare System.

Get in touch
Jump to a Topic:

About Abraham Lebenthal

Accolades
  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Top Doctor icon

    Top Doctor

  • VA Doctor icon

    VA Doctor

  • VAT Surgery icon

    Video-Assisted Thoracoscopic Surgery

  • Board Certified icon

    Board Certified in Surgery

  • Board Certified icon

    Board Certified in Thoracic Surgery

Get to Know Dr. Abraham Lebenthal

Dr. Abraham Lebenthal is passionate about working with patients diagnosed with malignant mesothelioma, a cancer alarmingly prevalent among military veterans and blue-collar workers.

He is the director of the Minimally Invasive Thoracic Surgery unit at the VA Healthcare System-West Roxbury campus, but he also has extensive experience in the most aggressive surgeries for pleural mesothelioma.

Lebenthal was recruited to Dana-Farber and trained by mesothelioma treatment pioneer and thoracic surgeon Dr. David Sugarbaker.

His clinical interests also include lung cancer, mediastinal tumors, thymic tumors, and esophageal cancer. He has experience with advanced laparoscopy and therapeutic endoscopy techniques.

Lebenthal performs surgery at Brigham & Women’s Hospital in Boston. He also is a professor at Harvard Medical School.

When it comes to this rare disease, Lebenthal talks extensively about tailoring mesothelioma treatment for every individual, being aggressive with his approach and “pushing the envelope” to find solutions.

Specialties of Dr. Abraham Lebenthal

Dr. Abraham Lebenthal’s Experience and Medical Education

  • Dana-Farber Cancer Institute/Brigham & Women’s Hospital

  • Harvard Medical School (Instructor)

  • VA Boston Healthcare System

  • Fox Chase Cancer Center

  • Mount Sinai Medical Center (Residency)

  • Hebrew University Medical Center (Residency)

  • Brigham & Women’s Hospital (Fellowship)

  • Hadassah Medical School, Hebrew University

Awards and Other Recognitions

  • Letter of Distinction for Bravery, Israeli Army

  • Golden Heart Award, VA Boston Healthcare System

  • Compassionate Doctor Award

  • Patient’s Choice 5th Anniversary Award

Clinical Trials Under Dr. Abraham Lebenthal

  • A multicenter phase II study of toxicity issues involving the combination of neoadjuvant chemotherapy and modulated radiation therapy in combination with pleurectomy and decortication surgery.

Learn More About COVID-19 and Mesothelioma

Learn About COVID-19 and Mesothelioma

Get a free recording of the COVID-19 and mesothelioma presentation hosted by the experts at The Mesothelioma Center.

Get Yours Now

Dr. Lebenthal’s Training Came the Hard Way

Lebenthal credits his Army training for much of the success, and the passion he exhibits, as a thoracic surgeon at Brigham & Women’s Hospital.

He served active duty as a battalion physician in an elite infantry unit within the Israeli Army after his graduation from medical school. It was there he received a Letter of Distinction for Bravery after evacuating combat soldiers under fire.

“One of the things you learn in the military is: There is no such thing as `I can’t.’ You learn to make good decisions,” he said. “You learn to take responsibility and ownership. And you better have precise execution. It’s the same in medicine.”

That training also attracted him to mesothelioma, the rare and aggressive cancer that has hit a disproportionate number of veterans exposed to asbestos, stemming from the military’s use of contaminated products.

“I have a deep admiration and respect for people who served in the military. It’s part of my background,” he said. “As in war, we don’t leave our brothers behind.”

See More Top Mesothelioma Doctors

Publications of Dr. Abraham Lebenthal

  • Ijsseldijk, M. et al. (2019). Survival After Stereotactic Body Radiation Therapy for Clinically Diagnosed or Biopsy-Proven Early-Stage NSCLC: A Systemic Review and Meta-Analysis. Journal of Thoracic Oncology.

  • Siegert, C. et al. (2017). Open access phone triage for veterans with suspected malignant pleural mesothelioma. Journal of Surgical Research.

  • Fisichella, M., Lebenthal, A. & Jalilvand, A. (2015). Diagnostic Evaluation of Achalasia: From the Whalebone to the Chicago Classification. World Journal of Surgery.

  • Paul, S. et al. (2007). Primary Ewing sarcoma invading the heart: resection and reconstruction. Journal of Cardiovascular Surgery.

Disclaimer: Dr. Abraham Lebenthal has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Asbestos.com Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at Asbestos.com
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 24, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now